Haematopoietic and immune defects associated with GATA2 mutation.
about
Approach to the patient with neutropenia in childhoodMissing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in ChildhoodNK Cell Influence on the Outcome of Primary Epstein-Barr Virus Infection'"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infectionHarnessing adaptive natural killer cells in cancer immunotherapyModeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome EngineeringNovel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignanciesThe genomics of inherited bone marrow failure: from mechanism to the clinic.Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.GATA factor mutations in hematologic disease.Cellular and Molecular Defects Underlying Invasive Fungal Infections-Revelations from Endemic Mycoses.Single-gene association between GATA-2 and autoimmune hepatitis: A novel genetic insight highlighting immunologic pathways to disease.Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency.Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity.Langerhans cell origin and regulation.Hematopoietic stem and progenitor cells as novel prognostic biomarkers of longevity in a murine model for amyotrophic lateral sclerosis.2014 Jeffrey M. Hoeg Award Lecture: Transcriptional Control of Monocyte Development.Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for hematologists.Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia.Characterization of human mitochondrial ferritin promoter: identification of transcription factors and evidences of epigenetic control.GATA2 deficiency and related myeloid neoplasms.Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia.Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency.Loss of c-Kit and bone marrow failure upon conditional removal of the GATA-2 C-terminal zinc finger domain in adult mice.New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing.Approach to a Child with Primary Immunodeficiency Made Simple.GATA2 Deficiency and Epstein-Barr Virus Disease.Skin manifestations among GATA2-deficient patients.Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history.Human dendritic cell subsets: an update.Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients
P2860
Q26777106-5D9E0103-7A66-4F37-B440-512ECCB58E8FQ26798389-2028ACAD-4071-4C09-BEBC-CC75B56FF6FCQ28069456-D396006E-318C-4028-8B48-2A5634422832Q28070339-3B1559DB-D6CD-44D4-8C76-DD7DD79A0716Q28081448-A1C11F5B-4CF5-4B5E-BA13-8FF826E78ACFQ28083303-03BDF216-3A34-4E26-A8CC-C00D55A99ED1Q28118904-05BAA024-EFAA-4C01-A406-3CD05804EBFDQ30235895-DDF52769-36EA-4A37-84E6-AEA73A0A2971Q33428604-856CEE36-78F7-438A-828D-3E005D983F3BQ33439175-02F5A815-7F38-4900-8FDD-B7F1C9251BE7Q33843057-27A3D2A6-DE61-4067-ABBF-607BCC33F6A0Q36777826-5F5BEF4A-4F04-4657-B6AA-36A877569BBCQ37559777-DF3D46C7-E352-448A-9D2F-0B90120D07E1Q38565478-04626448-9E62-45F9-A2E8-8AE7E07654C6Q38629610-5CDA5867-A156-4A58-A449-A36CECF363CCQ38816820-26CD9572-2E3F-4A15-AD3F-C7C855B40F75Q38888701-E8C455C5-7E43-4CD4-9338-472A441EF5CDQ39000607-A27C5A52-49F7-4A62-AF34-387CA3705930Q39284013-19D86D6D-1078-4537-B6CA-160D404D68ADQ39393833-6FCF624C-2D33-49A4-BFA1-E87F1BA71082Q40163308-1A339622-99EA-4DD1-8C51-BFC34DE70DB5Q40328357-6C892314-4338-4E5D-9CB0-15051B937840Q40656859-6E0C417B-7E5B-498B-9C74-A92CBF376F59Q40873857-51EBC50D-1CB6-456D-AFFA-07A6982D7E06Q46853118-503558DC-86DE-4AC1-9092-619298421BE9Q47095589-29B7B198-95CE-4BF4-8774-80EBB4EB25F9Q47548493-D2A6BFD6-25D8-4654-940A-E537B76285D3Q47910598-09D812D7-C34E-4CC5-B70D-F4FDFA66FAACQ48123477-7B605EF1-B05A-4967-833C-2C1421B02A99Q50125373-AD49FA46-72DF-473B-B711-4E733C2AF052Q57093252-ED67B9B2-A777-4C4F-A2DF-9B49AC706A5D
P2860
Haematopoietic and immune defects associated with GATA2 mutation.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Haematopoietic and immune defects associated with GATA2 mutation.
@ast
Haematopoietic and immune defects associated with GATA2 mutation.
@en
type
label
Haematopoietic and immune defects associated with GATA2 mutation.
@ast
Haematopoietic and immune defects associated with GATA2 mutation.
@en
prefLabel
Haematopoietic and immune defects associated with GATA2 mutation.
@ast
Haematopoietic and immune defects associated with GATA2 mutation.
@en
P2860
P921
P356
P1476
Haematopoietic and immune defects associated with GATA2 mutation.
@en
P2093
Matthew Collin
Rachel Dickinson
P2860
P304
P356
10.1111/BJH.13317
P407
P577
2015-02-23T00:00:00Z
2015-04-01T00:00:00Z